SolasCure Limited
EIC Accelerator Winner From 2023
Leveraging biomimicry and evidence-based medicine to treat patients with chronic wounds
United Kingdom
Articles
SolasCure Limited Secures EIC Accelerator Funding for Innovative Aurase Wound Gel Development
United KingdomEIC Accelerator2023
Read Article